Wistar rabies virus strain PM-1503-3M vaccine
Term · Oncology and biomedicine · MLC-T-ONC-017564
A vaccine containing inactivated Wistar rabies virus strain PM-1503-3M, with immunotherapeutic activity. Upon administration, Wistar rabies virus strain PM-1503-3M vaccine induces the formation of rabies-specific antibodies and rabies virus neutralizing antibodies (RVNA), which provide protection against rabies infection. This rabies vaccine can be used for both pre-exposure and post-exposure prophylaxis of rabies.
| Identifier | MLC-T-ONC-017564 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017564",
"term": "Wistar rabies virus strain PM-1503-3M vaccine",
"field": "Oncology and biomedicine",
"definition": "A vaccine containing inactivated Wistar rabies virus strain PM-1503-3M, with immunotherapeutic activity. Upon administration, Wistar rabies virus strain PM-1503-3M vaccine induces the formation of rabies-specific antibodies and rabies virus neutralizing antibodies (RVNA), which provide protection against rabies infection. This rabies vaccine can be used for both pre-exposure and post-exposure prophylaxis of rabies.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/wistar-rabies-virus-strain-pm-1503-3m-vaccine/"
}
Record 17,438 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.